Clinical Trial Update: Safety and Efficacy Study of Citalopram and Lithium for the Treatment of Depressive Mood Disorder Symptoms [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating the safety and efficacy of combining citalopram with lithium for depressive mood disorder symptoms in adults has completed, with resu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Borderline Personality Disorder
• Major Depressive Disorder
• Persistent Depressive Disorder

Drugs mentioned

• Citalopram (Citalopram hydrobromide)
• Lithium carbonate (Lithium carbonate)

Snippet

Sponsor: Columbia Northwest Pharmaceuticals | Conditions: Major Depressive Disorder, Dysthymia | Phase 2 | Status: COMPLETED | Results posted: 2011-06-08